Related references
Note: Only part of the references are listed.Dysregulation of HDAC9 Represses Trophoblast Cell Migration and Invasion Through TIMP3 Activation in Preeclampsia
Dandan Xie et al.
AMERICAN JOURNAL OF HYPERTENSION (2019)
Transcriptomic Profiling in Human Decidua of Severe Preeclampsia Detected by RNA Sequencing
Jing Tong et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Mapping the Mouse Cell Atlas by Microwell-Seq
Xiaoping Han et al.
CELL (2018)
Regulators of G protein signaling in cardiovascular function during pregnancy
Katherine J. Perschbacher et al.
PHYSIOLOGICAL GENOMICS (2018)
The perplexing pregnancy disorder preeclampsia: what next?
James M. Roberts
PHYSIOLOGICAL GENOMICS (2018)
Single-cell RNA-seq reveals the diversity of trophoblast subtypes and patterns of differentiation in the human placenta
Yawei Liu et al.
CELL RESEARCH (2018)
Single-cell reconstruction of the early maternal-fetal interface in humans
Roser Vento-Tormo et al.
NATURE (2018)
Arginine vasopressin infusion is sufficient to model clinical features of preeclampsia in mice
Jeremy A. Sandgren et al.
JCI INSIGHT (2018)
Preeclampsia: novel insights from global RNA profiling of trophoblast subpopulations
Matthew Gormley et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2017)
An RGS2 3′UTR polymorphism is associated with preeclampsia in overweight women
Tiina Karppanen et al.
BMC GENETICS (2016)
Role of endothelin in preeclampsia and hypertension following antiangiogenesis treatment
Langeza Saleh et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2016)
Unsupervised Placental Gene Expression Profiling Identifies Clinically Relevant Subclasses of Human Preeclampsia
Katherine Leavey et al.
HYPERTENSION (2016)
RGS2 squelches vascular Gi/o and Gq signaling to modulate myogenic tone and promote uterine blood flow
Li Jie et al.
PHYSIOLOGICAL REPORTS (2016)
Opposing tissue-specific roles of angiotensin in the pathogenesis of obesity, and implications for obesity-related hypertension
Nicole K. Littlejohn et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2015)
Identification of Histone Deacetylase Inhibitors with Benzoylhydrazide Scaffold that Selectively Inhibit Class I Histone Deacetylases
Yunfei Wang et al.
CHEMISTRY & BIOLOGY (2015)
The RGS2 (-391, C>G) Genetic Variation Correlates to Antihypertensive Drug Responses in Chinese Patients with Essential Hypertension
Fazhong He et al.
PLOS ONE (2015)
Regulator of G protein signaling 5 is a determinant of gestational hypertension and preeclampsia (Publication with Expression of Concern. See vol. 12, 2020)
Vasyl Holobotovskyy et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Extensive shift in placental transcriptome profile in preeclampsia and placental origin of adverse pregnancy outcomes
Siim Sober et al.
SCIENTIFIC REPORTS (2015)
Hypertension after preeclampsia and relation to the C1114G polymorphism (rs4606) in RGS2: data from the Norwegian HUNT2 study
Anne Stine Kvehaugen et al.
BMC MEDICAL GENETICS (2014)
Copeptin, a surrogate marker for arginine vasopressin secretion, is associated with higher glucose and insulin concentrations but not higher blood pressure in obese men
C. L. Asferg et al.
DIABETIC MEDICINE (2014)
Collection of a lifetime: A practical approach to developing a longitudinal collection of women's healthcare biological samples
Mark K. Santillan et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2014)
Vasopressin in Preeclampsia A Novel Very Early Human Pregnancy Biomarker and Clinically Relevant Mouse Model
Mark K. Santillan et al.
HYPERTENSION (2014)
Single Nucleotide Polymorphisms in G Protein Signaling Pathway Genes in Preeclampsia
Anne Stine Kvehaugen et al.
HYPERTENSION (2013)
Landscape of Transcriptional Deregulations in the Preeclamptic Placenta
Daniel Vaiman et al.
PLOS ONE (2013)
Integrative transcriptome analysis reveals dysregulation of canonical cancer molecular pathways in placenta leading to preeclampsia
Roxana Moslehi et al.
SCIENTIFIC REPORTS (2013)
Epigenetic repression of regulator of G-protein signaling 2 promotes androgen-independent prostate cancer cell growth
Dennis W. Wolff et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Regulator of G Protein Signaling 2 Deficiency Causes Endothelial Dysfunction and Impaired Endothelium-derived Hyperpolarizing Factor-mediated Relaxation by Dysregulating Gi/o Signaling
Patrick Osei-Owusu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Identification of a cAMP-response Element in the Regulator of G-protein Signaling-2 (RGS2) Promoter as a Key Cis-regulatory Element for RGS2 Transcriptional Regulation by Angiotensin II in Cultured Vascular Smooth Muscles
Zhongwen Xie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Differential placental gene expression in preeclampsia
Daniel A. Enquobahrie et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2008)
Autoantibody from women with preeclampsia induces soluble fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling
Cissy Chenyi Zhou et al.
HYPERTENSION (2008)
Reduced expression of regulator of G-protein signaling 2 (RGS2) in hypertensive patients increases calcium mobilization and ERK1/2 phosphorylation induced by angiotensin II
Andrea Semplicini et al.
JOURNAL OF HYPERTENSION (2006)
Genetic variations of regulator of G-protein signaling 2 in hypertensive patients and in the general population
J Yang et al.
JOURNAL OF HYPERTENSION (2005)
Deacetylase activity is required for cAMP activation of a subset of CREB target genes
DM Fass et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Share Paper
